Precerv Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hemostemix Inc : Hemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund Up To 75% of 5-Year Costs

Calgary, Alberta (Newsfile Corp. - January 23, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it is hiring four new biotechnologists

Thomas smeenkThomas abrahamWorld economic forum technology pioneer awardHemostemix incRegulation service providerAlberta newsfile corpVenture exchangePrecerv incManufacturing managerQuality control managerLooking informationCommon shares

Hemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund Up To 75% of 5-Year Costs

Hemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund Up To 75% of 5-Year Costs
investorintel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorintel.com Daily Mail and Mail on Sunday newspapers.

Thomas smeenkThomas abrahamWorld economic forum technology pioneer awardPrecerv inc

Hemostemix Inc : Hemostemix Announces NCP-01 Study to Address a $10 Billion Pain Market

Calgary, Alberta (Newsfile Corp. - October 19, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") and its wholly-owned subsidiary, PreCerv Inc., are pleased

Thomas smeenkThomas abrahamWorld economic forum technology pioneer awardHemostemix incRegulation service providerAlberta newsfile corpVenture exchangePrecerv incGlobal dataIschemic cardiomyopathyCritical limbLooking informationCommon shares

Hemostemix Announces NCP-01 Study to Address a $10 Billion Pain Market

Hemostemix Announces NCP-01 Study to Address a $10 Billion Pain Market
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thomas smeenkThomas abrahamWorld economic forum technology pioneer awardHemostemix incRegulation service providerAlberta newsfile corpVenture exchangePrecerv incGlobal dataIschemic cardiomyopathyCritical limb

Hemostemix Announces the Incorporation of PreCerv Inc And a Global Field of Use License to NCP-01

Hemostemix Announces the Incorporation of PreCerv Inc And a Global Field of Use License to NCP-01
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thomas smeenkWorld economic forum technology pioneer awardHemostemix incRegulation service providerAlberta newsfile corpVenture exchangePrecerv incWall streetIschemic cardiomyopathyDilated cardiomyopathyStem cell treatmentRegulating stem cellsVitro techniquesStem cellsNeural lineageAutomated cell